Volume 19, Issue 11 pp. 1141-1145
Article
Full Access

Synthesis, structure and antitumor activity of dibutyltin oxide complex with 5-fluorouracil derivatives

Dai-Shu Zuo

Dai-Shu Zuo

Marine Drug and Food Institute, Ocean University of Qingdao, Qingdao, Shandong 266003, China

Search for more papers by this author
Tao Jiang

Tao Jiang

Marine Drug and Food Institute, Ocean University of Qingdao, Qingdao, Shandong 266003, China

Search for more papers by this author
Hua-Shi Guan

Hua-Shi Guan

Marine Drug and Food Institute, Ocean University of Qingdao, Qingdao, Shandong 266003, China

Search for more papers by this author
Xin Qi

Xin Qi

Marine Drug and Food Institute, Ocean University of Qingdao, Qingdao, Shandong 266003, China

Search for more papers by this author
Kui-Qi Wang

Kui-Qi Wang

Marine Drug and Food Institute, Ocean University of Qingdao, Qingdao, Shandong 266003, China

Search for more papers by this author
Zhan Shi

Zhan Shi

Key Laboratory of Inorganic Synthesis and Preparative Chemistry, Jilin University, Changchun, Jilin 130022, China

Search for more papers by this author
First published: 26 August 2010
Citations: 3

Abstract

The dibutyltin(IV) oxide complex reacts with 5-fluorouracil-l-propanonic or5-fluorouracil-1-acetic acid to give the potential antitumor activity complexes [(5-fluorouracil)-1-(CH2)mCOOSn(Bu-n)2]4O2[m = 1, (1); m = 2, (2)] which were determined by IR and 1H NMR. The crystal structure determination shows that complex 2 is a dimmer, in which two [(5-fluorouracil)-1-CH2CH2COOSn(Bu-n)2]2O units are linked by bridging oxygen atom, and the tin atoms adopt distorted trigonal bipyramids via two carbons from dibutyl group and three oxygen atoms from 5-fluorouracil and bridging oxygen. In vitro test shows complexes 1 and 2 exhibit high cytotoxicity against OVCAR-3 and PC-14.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.